Real-time cell viability monitoring for high-throughput drug screening using tumor xenograft-derived cells
{{output}}
Patient-derived tumor xenografts (PDTXs) recapitulate the molecular and phenotypic heterogeneity of human cancers, making them valuable pre-clinical models for cancer drug development. However, high-throughput drug screening (HTDS) using ex vivo short-term cul... ...
